Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults

Overview

Journal J Clin Sleep Med

Specialties Neurology
Psychiatry

Date 2008 Oct 16

PMID 18853708

Citations 581

Authors

Sharon Schutte-Rodin

Lauren Broch

Daniel Buysse

Cynthia Dorsey

Michael Sateia

Affiliations

Soon will be listed here.

Abstract

Insomnia is the most prevalent sleep disorder in the general population, and is commonly encountered in medical practices. Insomnia is defined as the subjective perception of difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity for sleep, and that results in some form of daytime impairment.1 Insomnia may present with a variety of specific complaints and etiologies, making the evaluation and management of chronic insomnia demanding on a clinician's time. The purpose of this clinical guideline is to provide clinicians with a practical framework for the assessment and disease management of chronic adult insomnia, using existing evidence-based insomnia practice parameters where available, and consensus-based recommendations to bridge areas where such parameters do not exist. Unless otherwise stated, "insomnia" refers to chronic insomnia, which is present for at least a month, as opposed to acute or transient insomnia, which may last days to weeks.

Citing Articles

Comparison of diaphragmatic breathing relaxation training and cognitive-behavioral therapy on sleep quality in the elderly: a randomized clinical trial.

Kakuei A, Ravari A, Mirzaei T, Kamiab Z, Bahrami R Sleep Breath. 2025; 29(2):131.

PMID: 40085337 DOI: 10.1007/s11325-025-03296-1.

Association Between Insomnia and Healthcare Utilization: A Scoping Review of the Literature.

Olatunde K, Patton S Am J Lifestyle Med. 2025; 19(3):403-418.

PMID: 40041311 PMC: 11873877. DOI: 10.1177/15598276231164953.

Pharmacological and psychological approaches to insomnia treatment in cardiac patients: a narrative literature review.

Stapel B, Alvarenga M, Kahl K Front Psychiatry. 2025; 16:1490585.

PMID: 40018681 PMC: 11865029. DOI: 10.3389/fpsyt.2025.1490585.

Concussion and the Autonomic, Immune, and Endocrine Systems: An Introduction to the Field and a Treatment Framework for Persisting Symptoms.

Pertab J, Merkley T, Winiarski H, Cramond K, Cramond A J Pers Med. 2025; 15(1).

PMID: 39852225 PMC: 11766534. DOI: 10.3390/jpm15010033.

Comparing Effects of Aromatherapy with Five Herbs Essential Oils on PCPA-induced Insomnia Mice.

Feng P, Chen J, Chen X, Tang M, Song N, Zhang L J Microbiol Biotechnol. 2025; 35:e2409021.

PMID: 39848678 PMC: 11813366. DOI: 10.4014/jmb.2409.09021.

References

Sackett D . Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol. 1993; 9(6):487-9. View

Hauri P . Consulting about insomnia: a method and some preliminary data. Sleep. 1993; 16(4):344-50. DOI: 10.1093/sleep/16.4.344. View

Perlis M, Giles D, Mendelson W, Bootzin R, Wyatt J . Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res. 1997; 6(3):179-88. DOI: 10.1046/j.1365-2869.1997.00045.x. View

Nowell P, Mazumdar S, Buysse D, Dew M, Reynolds 3rd C, Kupfer D . Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA. 1998; 278(24):2170-7. View

Hauri P . Can we mix behavioral therapy with hypnotics when treating insomniacs?. Sleep. 1998; 20(12):1111-8. DOI: 10.1093/sleep/20.12.1111. View

Morin C, Colecchi C, Stone J, Sood R, BRINK D . Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999; 281(11):991-9. DOI: 10.1001/jama.281.11.991. View

Ancoli-Israel S, Roth T . Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999; 22 Suppl 2:S347-53. View

Taylor D, Lichstein K, Heith Durrence H . Insomnia as a health risk factor. Behav Sleep Med. 2004; 1(4):227-47. DOI: 10.1207/S15402010BSM0104_5. View

Brzezinski A, Vangel M, Wurtman R, Norrie G, Zhdanova I, Ben-Shushan A . Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev. 2005; 9(1):41-50. DOI: 10.1016/j.smrv.2004.06.004. View

10.

Edinger J, Bonnet M, Bootzin R, Doghramji K, Dorsey C, Espie C . Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep. 2005; 27(8):1567-96. DOI: 10.1093/sleep/27.8.1567. View

11.

Littner M, Kushida C, Wise M, Davila D, Morgenthaler T, Lee-Chiong T . Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005; 28(1):113-21. DOI: 10.1093/sleep/28.1.113. View

12.

Ancoli-Israel S, Richardson G, Mangano R, Jenkins L, Hall P, Jones W . Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med. 2005; 6(2):107-13. DOI: 10.1016/j.sleep.2004.10.015. View

13.

Barbera J, Shapiro C . Benefit-risk assessment of zaleplon in the treatment of insomnia. Drug Saf. 2005; 28(4):301-18. DOI: 10.2165/00002018-200528040-00003. View

14.

Mendelson W . A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005; 66(4):469-76. DOI: 10.4088/jcp.v66n0409. View

15.

Avidan A, Fries B, James M, Szafara K, Wright G, Chervin R . Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc. 2005; 53(6):955-62. DOI: 10.1111/j.1532-5415.2005.53304.x. View

16.

Allain H, Bentue-Ferrer D, Polard E, Akwa Y, Patat A . Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging. 2005; 22(9):749-65. DOI: 10.2165/00002512-200522090-00004. View

17.

Roth T, Stubbs C, Walsh J . Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep. 2005; 28(3):303-7. View

18.

. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep. 2005; 28(9):1049-57. DOI: 10.1093/sleep/28.9.1049. View

19.

Roth T, Walsh J, Krystal A, Wessel T, Roehrs T . An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med. 2005; 6(6):487-95. DOI: 10.1016/j.sleep.2005.06.004. View

20.

Glass J, Lanctot K, Herrmann N, Sproule B, Busto U . Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005; 331(7526):1169. PMC: 1285093. DOI: 10.1136/bmj.38623.768588.47. View